Drug incompatibility prevention and management: A Comprehensive review

Authors

  • Faris Mohammed Alshehri, Nasser Abdullah Aldosari, Ayed Saad Rashed Aldosari, Hammad Khalf Hammad Aldoasri, Ahmed Mohammed Aldoasri, Wejdan Saeed Al Zaidi, Ahmed Qasem Tawhari
  • Mohammad Abdullah Althagafi, Ibrahim Saad Al-Mutairi, Turki Saeed Alahmari, Sayel Abdul Hadi Al-Shalawi, Aiman Mohammed Awaji

DOI:

https://doi.org/10.63278/jicrcr.vi.2595

Abstract

Drug incompatibility is a critical concern in clinical practice, particularly in settings where multiple medications are administered concurrently, such as hospitals and during complex treatment regimens. This comprehensive review explores the multifaceted nature of drug incompatibility, encompassing its definitions, types, mechanisms, risk factors, and strategies for prevention and management. Drug incompatibility can manifest as physical, chemical, or therapeutic interactions, each with distinct implications for patient safety and treatment efficacy. Physical incompatibilities often arise during the preparation and administration of intravenous medications, leading to visible changes such as precipitation or color alteration. Chemical incompatibilities involve alterations in drug structure, potentially resulting in inactive or toxic products. Therapeutic incompatibilities occur when the combined effects of drugs are diminished, leading to suboptimal therapeutic outcomes. The review highlights the increasing complexity of modern medicine, characterized by polypharmacy and the rising prevalence of chronic conditions, which heightens the risk of drug interactions. It emphasizes the importance of understanding the pharmacokinetics and pharmacodynamics of medications, as well as patient-specific factors that contribute to incompatibility. Effective prevention strategies include the implementation of evidence-based guidelines, the use of computerized physician order entry systems with built-in alerts, and the establishment of standardized protocols for medication administration. Management of drug incompatibility requires prompt recognition and intervention, including discontinuation of incompatible drugs and close monitoring of patients for adverse reactions. The role of technology, such as electronic health records and clinical decision support systems, is also discussed as a means to enhance communication and improve medication safety. Finally, the review underscores the necessity of ongoing education and training for healthcare professionals to foster a culture of safety and vigilance in medication management. By addressing the complexities of drug incompatibility, this review aims to equip healthcare providers with the knowledge and tools necessary to optimize patient care and minimize the risks associated with drug interactions.

Downloads

Published

2024-11-20

How to Cite

Faris Mohammed Alshehri, Nasser Abdullah Aldosari, Ayed Saad Rashed Aldosari, Hammad Khalf Hammad Aldoasri, Ahmed Mohammed Aldoasri, Wejdan Saeed Al Zaidi, Ahmed Qasem Tawhari, & Mohammad Abdullah Althagafi, Ibrahim Saad Al-Mutairi, Turki Saeed Alahmari, Sayel Abdul Hadi Al-Shalawi, Aiman Mohammed Awaji. (2024). Drug incompatibility prevention and management: A Comprehensive review. Journal of International Crisis and Risk Communication Research , 3017–3024. https://doi.org/10.63278/jicrcr.vi.2595

Issue

Section

Articles